Yesterday evening, I joined global health partners from the COVID-19 ACT-Accelerator to announce a ground-breaking agreement that will provide access to 120 million rapid tests for COVID-19 to low-and middle-income countries.
We ended 2019 with a palpable sense of excitement and expectation. More people were receiving lifesaving treatment for HIV, tuberculosis, and malaria than ever before. And a record-breaking fundraising conference meant we had the resources to get the...
With personal protective equipment, radio broadcasts and innovative mosquito net campaigns, countries are fighting COVID-19, shoring up health systems, and mitigating the impacts on lifesaving HIV, TB and malaria programs. The Global Fund is supporti...
Eswatini, a tiny country of just over a million people in southern Africa, has one of the highest HIV prevalence rates in the world: 27% of adults live with the disease.
In Cape Town, South Africa, Nombasa Krune-Dumile, a drug-resistant tuberculosis counselor who has dedicated her life to supporting tuberculosis (TB) patients, says COVID-19 has devastated health systems and upended normal operations of her work.
Every time Evaline Owuor says goodbye to her children and goes to work, she takes a calculated risk. As a community health worker in Kenya’s Homa Bay County, she has helped her community dramatically reduce the number of people who die from malaria. ...
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website.
To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.